Curcumin in Treating Patients With Familial Adenomatous Polyposis

Research Group
Gastrointestinal and Other Cancers
Sponsor
National Cancer Institute (NCI)
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT00641147
This randomized phase II trial studies curcumin in treating patients with familial adenomatous polyposis. Curcumin may prevent colorectal cancer in patients with a history of rectal polyps or colorectal neoplasia.
Intervention
Curcumin, Laboratory Biomarker Analysis, Placebo
Condition
Familial Adenomatous Polyposis
Investigators
Francis Giardiello

See list of participating sites